SCHEMBL1480337

SCHEMBL1480337

C=CCCC(=O)C1=CC(C)(C)CCC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16322603 0.84 — —
SCHEMBL7776081 0.83 — —
SCHEMBL7776631 0.82 MEN1 (0.30) ALDH1A1
SCHEMBL11519504 0.81 HSD17B3 (0.34) ALDH1A1TDP1
SCHEMBL11373278 0.78 PTPN1 (0.30) —
SCHEMBL7771790 0.77 — —
SCHEMBL7771864 0.76 MEN1 (0.30) ALDH1A1
SCHEMBL5572872 0.76 PTGS2 (0.32) ALDH1A1
SCHEMBL14879777 0.76 AKT1 (0.31) ALDH1A1TDP1
SCHEMBL11369856 0.74 FAAH (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 492 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation GIVAUDAN SA (CH) 2026-03-31 — — US claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 — — US claimed
US-20230392098-A1 IMPROVED FRESHNESS IMPARTING COMPOSITIONS FIRMENICH SA (CH) 2023-12-07 — — US claimed
US-20230340374-A1 Improvements in or Relating to Organic Compounds GIVAUDAN SA (CH) 2023-10-26 — — US claimed
CN-116807912-A Use of volatile components to limit or eliminate perception of malodor 弗门尼舍有限公司 2023-09-29 — — CN claimed
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR FIRMENICH SA (CH) 2023-07-27 — — US claimed
EP-4208527-A1 IMPROVED FRESHNESS IMPARTING COMPOSITIONS Firmenich SA (CH) 2023-07-12 — — EP claimed
CN-116391022-A Improved freshness imparting compositions 弗门尼舍有限公司 2023-07-04 — — CN claimed
CN-111432851-B Use of volatile components to limit or eliminate perception of malodor 弗门尼舍有限公司 2023-06-23 — — CN claimed
US-20230166230-A1 ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION GIVAUDAN SA (CH) 2023-06-01 — — US claimed
US-9334464-B2 Microcapsules and uses thereof FIRMENICH SA (CH) 2016-05-10 — — US claimed
US-9315763-B2 Photolabile latex for the release of perfumes FIRMENICH SA (CH) 2016-04-19 — — US claimed
EP-2282980-B1 SYNTHESIS OF MONO-KETONES FROM 1,3-DIKETONES DSM IP ASSETS BV (NL) 2016-02-24 — — EP claimed
WO-2015181257-A2 PERFUME COMPOSITIONS GIVAUDAN SA (CH) 2015-12-03 — — WO claimed
US-20140323376-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2014-10-30 — — US claimed
US-20080108542-A1 Ingredients; hydrocarbons having from 8 to 13 carbon atoms, ethers, aldehydes, esters, nitriles, alcohols, ketones; at least three of the groups must each comprise materials amounting to at least 5% by weight of the perfume composition QUEST INTERNATIONAL SERVICES, B.V. (NL) 2008-05-08 — — US claimed
EP-1855761-A1 PERFUME COMPOSITIONS Quest International Services B.V. (NL) 2007-11-21 — — EP claimed
WO-2006095200-A1 PERFUME COMPOSITIONS QUEST INTERNATIONAL SERVICES B.V. (NL) 2006-09-14 — — WO claimed
EP-0953562-A1 Beta, gamma-unsaturated delta-keto esters Givaudan Roure (International) S.A. (CH) 1999-11-03 — — EP claimed
US-4147672-A Cyclic C6 ketones in perfumes FIRMENICH SA (CH) 1979-04-03 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589377-B2 Encapsulated composition comprising core-shell microcapsules and process for its preparation CUTA, EXOC1, EXOSC10 ALDH1A1 2581/4885TDP1 1746/4885
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 ALDH1A1 205/4885TDP1 3363/4885
US-20230233425-A1 USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR TAS2R8, TRPA1, TAS2R10 ALDH1A1 831/4885TDP1 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback